Erythropoietin for the treatment of anemia in patients with hematologic disorders
This article introduces common data and our experience concerning the treatment with recombinant human erythropoietin anemia (r-HuEPO) in anemic patients with different disorders. We cited as an example some results of Eprex (Janssen-Cilag) therapy for patients with hematologic disorders in Russia....
Main Authors: | , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
ABV-press
2022-11-01
|
Series: | Онкогематология |
Subjects: | |
Online Access: | https://oncohematology.abvpress.ru/ongm/article/view/642 |